1. Arian-Schad KS, Kapp DS, Hackl A, Juettner FM, Leitner H, Porsch G, Lahousen M, Pickel H (1990) Radiation therapy in stage Ill ovarian cancer following surgery and chemotherapy. Prognostic factors, patterns of relapse, and toxicity: A preliminary report. Gynecol Oncol 39: 47–55
2. Barakat RR, Rubin SC, Wong G, Saigo PE, Markman M, Hoskins WJ (1992) Mixed mesodermal tumor of the ovary. Analysis of prognostic factors in 31 cases. Obstet Gynecol 80: 660–664
3. Berek JS (1992) Second-look versus second-nature. Gynecol Oncol 44: 1–2
4. Berek JS, Welander C, Schink JC, Grossberg H, Montz FJ, Zigelbeom J (1991) A phase 1–11 trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancer. Gynecol Oncol 40: 237–243
5. Bolls G, Zanaboni F, Vanoli P, Russo A, Franchi M, Scarfone G, Pecorelli S (1990) The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy. Gynecol Oncol 39: 150–154